Circulating tumorous cells in patients with hepatocellular carcinoma. Clinical impact and future directions

Author： Paterlini-Bréchot P.   vona G.   Bréchot C.  

Publisher： Academic Press

ISSN： 1044-579X

Source： Seminars in Cancer Biology, Vol.10, Iss.3, 2000-06, pp. : 241-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating LTD4 in patients with hepatocellular carcinoma

By Zhou Yan  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 139-144

Springer Publishing Company

Access to resources Recommend Favorite

Clinical characteristics of hepatocellular carcinoma in elderly patients

By                  

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 851-854

Spandidos Publications

Access to resources Recommend Favorite

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma

By Berruti A.   Dogliotti L.   Mosca A.   Gorzegno G.   Bollito E.   Mari M.   Tarabuzzi R.   Poggio M.   Torta M.   Fontana D.   Angeli A.  

Annals of Oncology, Vol. 12, Iss. 2, 2001-02 ,pp. : 153-157

Springer Publishing Company

Access to resources Recommend Favorite

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma

By Kondo Shunsuke  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 207-213

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Tumor Circulating Cells by Cytokeratin 20 in the Blood of Patients with Endometrial Carcinoma

By Klein A.   Fishman A.   Zemer R.   Zimlichman S.   Altaras M.M.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 352-355

Elsevier

Access to resources Recommend Favorite